Alps Advisors Inc. trimmed its stake in athenahealth, Inc (NASDAQ:ATHN) by 4.5% during the fourth quarter, Holdings Channel reports. The fund owned 3,993 shares of the health services provider’s stock after selling 186 shares during the period. Alps Advisors Inc.’s holdings in athenahealth were worth $527,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors also recently modified their holdings of ATHN. Northern Trust Corp increased its position in shares of athenahealth by 1.1% during the 2nd quarter. Northern Trust Corp now owns 233,577 shares of the health services provider’s stock worth $37,171,000 after purchasing an additional 2,431 shares during the last quarter. MERIAN GLOBAL INVESTORS UK Ltd acquired a new stake in shares of athenahealth during the 3rd quarter worth about $106,074,000. Highland Capital Management LLC acquired a new stake in shares of athenahealth during the 3rd quarter worth about $1,124,000. Oakbrook Investments LLC acquired a new stake in shares of athenahealth during the 3rd quarter worth about $337,000. Finally, Peregrine Capital Management LLC increased its position in shares of athenahealth by 2.7% during the 3rd quarter. Peregrine Capital Management LLC now owns 134,367 shares of the health services provider’s stock worth $17,951,000 after purchasing an additional 3,534 shares during the last quarter. Institutional investors and hedge funds own 94.33% of the company’s stock.
Several equities analysts have weighed in on the company. BidaskClub downgraded athenahealth from a “sell” rating to a “strong sell” rating in a research report on Thursday, February 7th. ValuEngine downgraded athenahealth from a “buy” rating to a “hold” rating in a research report on Wednesday, January 9th. Morgan Stanley lifted their target price on athenahealth from $128.00 to $135.00 and gave the company an “equal weight” rating in a research report on Monday, December 3rd. Wells Fargo & Co downgraded athenahealth from an “outperform” rating to a “market perform” rating and set a $135.00 target price for the company. in a research report on Tuesday, November 27th. Finally, Canaccord Genuity dropped their target price on athenahealth from $160.00 to $135.00 and set a “hold” rating for the company in a research report on Tuesday, November 13th. One investment analyst has rated the stock with a sell rating, twenty have assigned a hold rating and three have given a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and a consensus price target of $147.71.
athenahealth, Inc, together with its subsidiaries, provides network-based medical record, revenue cycle, patient engagement, care coordination, and population health services for medical groups and health systems. It offers athenaCollector, a network-enabled billing and practice management solution; athenaClinicals, an electronic health record for managing patient's clinical documentation; athenaCommunicator, an engagement and communication solution that provides an automated communication service between patients and provider practices for interactions outside the exam room; and athenaCoordinator for order transmission and care coordination services.
Featured Article: Asset Allocation, Balancing Your Investments
Want to see what other hedge funds are holding ATHN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for athenahealth, Inc (NASDAQ:ATHN).
Receive News & Ratings for athenahealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth and related companies with MarketBeat.com's FREE daily email newsletter.